neurogastroenterol motil off j europ gastrointestin motil soc 233187-192kennedy pj cryan jf dinan tg clarke g 2014 irritable bowel syndrome a microbiome-gut-brain axis disorder world j gastroenterol 203914105-14125o'malley d quigley em dinan tg cryan jf 2011 do inter- actions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome brain behav immun 2571333-1341santos j alonso c vicario m ramos l lobo b malagelada jr 2008 neuropharmacology of stress-induced mucosal inflamma- tion implications for inflammatory bowel disease and irritable bowel syndrome.

j nutr 1342479-482dicksved j halfvarson j rosenquist m jarnerot g tysk c apajalahti j engstrand l jansson jk 2008 molecular analysis of the gut microbiota of identical twins with crohn's disease.

microbiologica 53185-194kassinen a krogius-kurikka l makivuokko h rinttila t paulin l corander j malinen e apajalahti j palva a 2007 the fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.

am j gastroenterol 1002373-382matto j maunuksela l kajander k et al 2005 composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in ibs and control subjects.

world j gastroenterol 15475936parkes gc rayment nb hudspith bn petrovska l lomer mc brostoff j whelan k sanderson jd 2012 distinct microbial populations exist in the mucosa-associated microbiota of sub- groups of irritable bowel syndrome.

world j gastroenterol 10121802-1805carroll im chang yh park j sartor rb ringel y 2010 luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.

gut pathogens 2119krogius-kurikka l lyra a malinen e aarnikunnas j tuimala j paulin l makivuokko h kajander k palva a 2009 microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.

aliment pharmacol ther 414342-351jalanka-tuovinen j salojarvi j salonen a immonen o garsed k kelly fm zaitoun a palva a spiller rc de vos wm 2014 faecal microbiota composition and host-microbe cross-talk fol- lowing gastroenteritis and in postinfectious irritable bowel syn- drome.

clin gastroenterol hepatol off clin pract j am gastroenterologic assoc 35442-448silk db davis a vulevic j tzortzis g gibson gr 2009 clinical trial the effects of a trans-galactooligosaccharide prebiot- ic on faecal microbiota and symptoms in irritable bowel syn- drome.

lactobacillus salivarius ucc4331 1 x 1010cfuday or bifidobacterium infantis 35624 1 x 1010 cfuday362 ibs4 weekscomposite ibs score decrease efficacy variable of scores for bloating bowel dysfunction incomplete evacuation straining and the passage of gas77 ibs8 weeksthe bowel movement frequency and consistency were improved composite and individual scores for abdominal paindiscomfort bloatingdistention and bowel movement difficulty were significantly lower il-10il-12 ratio was normalizedligaarden et al.

nat immunol 36583- 590vivinus-nebot m frin-mathy g bzioueche h dainese r bernard g anty r filippi j saint-paul mc tulic mk verhasselt vet al 2014 functional bowel symptoms in quiescent inflammatory bowel diseases role of epithelial barrier disruption and low-grade inflammation.

gastroenterology epub ahead of printgibson pr 2017 the evidence base for efficacy of the low fodmap diet in irritable bowel syndrome is it ready for prime time as a first-line therapy j gastroenterol hepatol 32suppl 1 32-35pimentel m chow ej lin hc 2003 normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome.

world j gastroenterol 21257621- 7636chey wd kurlander j eswaran s 2015 irritable bowel syn- drome a clinical review.

j infect 2911-3neal kr hebden j spiller r 1997 prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome postal survey of patients.

am j gastroenterol 10171581-1590o'mahony l mccarthy j kelly p hurley g luo f chen k o'sullivan gc kiely b collins jk shanahan f et al 2005 lactobacillus and bifidobacterium in irritable bowel syndrome symptom responses and relationship to cytokine profiles.

